TEVA

7 Pharmaceutical Stocks That Just Raised Prices This Year

By Bret Kenwell, InvestorPlace Contributor
Pharmaceutical stocks have been on the rebound and many are raising their prices this year. What does that mean for business?

Value Investors Should Buy into the Teva Stock Dip

By Chris Lau, InvestorPlace Contributor
Teva stock is now at yearly lows, a victim of negative macro news, falling stock markets, and year-end tax-loss selling.

Should Warren Buffett — And You — Buy More TEVA Stock Right Now?

By Aaron Levitt, InvestorPlace Contributor
Teva's turnaround is working, but a serious worry is now hitting shares. Should you be buying more TEVA stock with this looming danger?

6 Pharmaceutical Stocks to Buy After the Midterms

By Chris Lau, InvestorPlace Contributor
The upside case for pharmaceutical stocks is building. The midterm elections results mean its unlikely drug price regulation will happen soon.

Even Following the Latest Surge, Mylan Stock Has Plenty of Room to Grow

By Chris Lau, InvestorPlace Contributor
Mylan stock jumped ahead following quarterly earnings that impressed investors. Management will continue doing better than expected.

5 Stocks to Buy From Goldman Sachs’ Conviction Buy List

By Harriet Lefton, Writer, TipRanks
The market is looking undeniably choppy right now but Goldman Sachs is staying upbeat. Here I dive into five top stocks to buy highlighted by GS as "Conviction Buys."

7 Stocks Warren Buffett Can’t Stop Buying

By Harriet Lefton, Writer, TipRanks
Just-released SEC forms reveal a valuable glimpse into which stocks Warren Buffett likes, and which he doesn’t. These are the stocks he poured money into in the second quarter.

Teva Wins Approval From FDA for Blockbuster Migraine Drug

By Chris Lau, InvestorPlace Contributor
The markets are ignoring the potential sales growth for Teva's migraine drug. Value investors should look at Teva stock now.

5 Top Stock Trades for Tuesday — Trading Oracle, FedEx Earnings

By Bret Kenwell, InvestorPlace Contributor
FedEx and Oracle are set to report earnings, while JD and Teva were in the news as we manage our top stock trades heading into Tuesday. Here's what you need to know.

Why Teva’s Outlook Is Mixed

By Josh Enomoto, InvestorPlace Contributor
TEVA stock is on a comeback rally after suffering two years of horrific losses, but its outlook is mixed.

5 Drug Stocks to Buy While the Pharma Sector Is on Sale

By Luke Lango, InvestorPlace Senior Investment Analyst
Drug stocks have been beaten up ever since the 2015 collapse of Valeant, but many of them are now too cheap to ignore.

EpiPen Shortage 2018: 13 Things for Parents to Know

By William White, InvestorPlace Writer
An EpiPen shortage has parents worried as the school season starts back up across the U.S., but there are other options.

5 Top Stock Trades for Friday Morning — Trading Nvidia Earnings

By Bret Kenwell, InvestorPlace Contributor
Here are the trading levels to keep in mind for Nvidia. Walmart, J.C. Penney and JD.com all post huge moves after reporting their quarterly results. Here are our top stock trades for Friday.

Why Teva Pharmaceutical Stock Is Sinking Today

By William White, InvestorPlace Writer
Teva Pharmaceutical (TEVA) stock was down on Thursday following the release of its earnings report for the second quarter of 2018.

5 Pharmaceutical and Biotech Stocks to Consider for July

By Chris Lau, InvestorPlace Contributor
Pfizer renewed the drug price hike cycle after it raised them for around 40 products. If other biotech stocks follow, profits will soar.

Teva Pharmaceutical Industries Limited Stock Still Is a Deep Value Play

By Chris Lau, InvestorPlace Contributor
Teva Pharmaceuticals is quietly moving higher on the stock market for good reason: worries over pricing and the impact of competition in generics is getting clearer. Teva stock is a great long-term bet.

5 Top Stock Trades for Tuesday Morning

By Bret Kenwell, InvestorPlace Contributor
Friday was a quiet session in the stock market, particularly with the holiday on Monday coming up. Here are our top stock trades to make when the markets resume trading after Memorial Day.

Warren Buffett Loves TEVA Stock and You Should Too

By Bret Kenwell, InvestorPlace Contributor
Teva Pharmaceuticals has been on the run, and a nod of confidence from Warren Buffett certainly helps matters. Teva stock can continue to rally if momentum stays with it.

FDA Shame List: 40 Drug Makers That Try to Block Generic Drugs

By Karl Utermohlen, InvestorPlace Writer
The Food and Drug Administration (FDA) announced a list of drug makers that have tried to block generic drugs in its new shame list. Here they are.
Load More